Ryoichi Matsunuma

Central Nervous System Symptom Burden and Clinical Implications for Antiemetic Management with Olanzapine in AC Chemotherapy

Ryoko Udagawa, Mototsugu Shimokawa, Hirotoshi Iihara, Rie Ozeki et autres

us, jp (code pays fourni par la source)

A randomized phase III trial of dexamethasone mouthwash to prevent chemotherapy-induced oral mucositis in patients with breast cancer.

Sayaka Kuba, Yasuhiro Hagiwara, 柴田伸弘, Takafumi Sangai et autres

jp, gb, ch (code pays fourni par la source)

Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness)

Tomoe Taji, Yukari Uemura, Yuri Kimura, Noriko Maeda et autres

jp (code pays fourni par la source)

Abstract PS2-06-30: Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with HER2-negative recurrent high-risk early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness)

Tomoe Taji, Mikiko Uemura, Yuri Kimura, Noriko Maeda et autres

jp (code pays fourni par la source)

Abstract PS1-01-03: Impact of Dexamethasone Premedication Timing on Infusion Reactions in HER2 Positive Breast Cancer

Ryoichi Matsunuma, Shigeru Nakagaki, E. Nakatani, Masayuki Kikuchi et autres

jp (code pays fourni par la source)

Sequential Multiple-Organ Immune-Related Adverse Events during and after Pembrolizumab Therapy in Triple-Negative Breast Cancer: A Case Report

Sae Imada, Shoko Sato, Naoko Hirose, Ryosuke Hayami et autres

jp (code pays fourni par la source)

DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer

Purba Singh, Charles M. Perou, Cheng Fan, Jonathan T. Lei et autres

us (code pays fourni par la source)

CD44 knockdown and TGF‑β inhibition modulate cell proliferation and invasion in claudin‑low breast cancer cells

Ryoichi Matsunuma, Kazuo Kinoshita, Sae Imada, Ai Sato et autres

jp (code pays fourni par la source)

Impact of modified dexamethasone administration sequence on infusion reaction incidence in HER2-positive breast cancer: a randomized multicenter trial

Ryoichi Matsunuma, Shigeru Nakagaki, Eiji Nakatani, Masayuki Kikuchi et autres

jp (code pays fourni par la source)

Abstract P2-04-06: Enhancement of TGF-β Receptor Inhibitor Efficacy through CD44 Suppression in Claudin-low Breast Cancer

Ryoichi Matsunuma, Sae Imada, Ai Sato, Ryosuke Hayami et autres

A randomized phase III study evaluating dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in patients with breast cancer

Sayaka Kuba, Sakiko Soutome, Yasuhiro Hagiwara, Yuichiro Kikawa et autres

jp, gb, ch (code pays fourni par la source)

Abstract PO2-06-04: Prospective study on eribulin efficacy in advanced and metastatic breast cancer: changes in TGF-β compared to other standard chemotherapy agents (KBCSG-TR 2018, POTENTIAL)

Takahiro Nakayama, Tersuhiro Yoshinami, Fumie Fujisawa, Minako Nishio et autres

jp, ve, gr (code pays fourni par la source)